US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist
  • 1.6100
  • +0.0400+2.55%
Close Sep 27 16:00 ET
  • 1.6100
  • 0.00000.00%
Post 20:01 ET
105.40MMarket Cap-1341P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
67.60%12.26M
19.77%8.83M
10.16%31.11M
19.73%8.3M
7.43%8.13M
1.95%7.32M
12.18%7.37M
1.52%28.24M
-0.40%6.93M
-10.17%7.56M
Selling and administrative expenses
68.92%3.95M
13.99%2.79M
1.30%9.96M
14.33%2.54M
17.04%2.64M
-5.19%2.34M
-15.43%2.44M
-1.93%9.83M
-13.01%2.22M
-10.02%2.25M
-General and administrative expense
68.92%3.95M
13.99%2.79M
1.30%9.96M
14.33%2.54M
17.04%2.64M
-5.19%2.34M
-15.43%2.44M
-1.93%9.83M
-13.01%2.22M
-10.02%2.25M
Research and development costs
66.98%8.31M
22.64%6.04M
14.89%21.15M
22.28%5.76M
3.35%5.49M
5.69%4.98M
33.87%4.93M
3.46%18.41M
6.89%4.71M
-10.23%5.31M
Operating profit
-67.60%-12.26M
-19.77%-8.83M
-10.16%-31.11M
-19.73%-8.3M
-7.43%-8.13M
-1.95%-7.32M
-12.18%-7.37M
-1.52%-28.24M
0.40%-6.93M
10.17%-7.56M
Net non-operating interest income expense
304.29%1.23M
55.22%357K
1,392.77%1.07M
74.45%239K
2,408.33%301K
465.06%303K
254.36%230K
-1,022.22%-83K
179.19%137K
105.74%12K
Non-operating interest income
172.40%1.28M
5.54%438K
177.19%1.68M
6.01%353K
134.22%438K
496.20%471K
6,816.67%415K
-29.98%605K
712.20%333K
18,600.00%187K
Non-operating interest expense
-65.48%58K
-56.22%81K
-12.21%604K
-41.84%114K
-21.71%137K
3.70%168K
19.35%185K
-19.53%688K
-8.41%196K
-16.67%175K
Other net income (expense)
Income before tax
-57.37%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.39%-7.01M
-6.27%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
Income tax
0.00%1K
0.00%1K
0
0
1K
0.00%1K
0
0
Net income
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
Net income continuous Operations
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
Minority interest income
Net income attributable to the parent company
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
Basic earnings per share
54.05%-0.17
30.95%-0.29
15.05%-1.58
2.50%-0.39
20.00%-0.4
26.00%-0.37
8.70%-0.42
42.59%-1.86
42.86%-0.4
49.49%-0.5
Diluted earnings per share
54.05%-0.17
30.95%-0.29
15.05%-1.58
2.50%-0.39
20.00%-0.4
26.00%-0.37
8.70%-0.42
42.59%-1.86
42.86%-0.4
49.49%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 67.60%12.26M19.77%8.83M10.16%31.11M19.73%8.3M7.43%8.13M1.95%7.32M12.18%7.37M1.52%28.24M-0.40%6.93M-10.17%7.56M
Selling and administrative expenses 68.92%3.95M13.99%2.79M1.30%9.96M14.33%2.54M17.04%2.64M-5.19%2.34M-15.43%2.44M-1.93%9.83M-13.01%2.22M-10.02%2.25M
-General and administrative expense 68.92%3.95M13.99%2.79M1.30%9.96M14.33%2.54M17.04%2.64M-5.19%2.34M-15.43%2.44M-1.93%9.83M-13.01%2.22M-10.02%2.25M
Research and development costs 66.98%8.31M22.64%6.04M14.89%21.15M22.28%5.76M3.35%5.49M5.69%4.98M33.87%4.93M3.46%18.41M6.89%4.71M-10.23%5.31M
Operating profit -67.60%-12.26M-19.77%-8.83M-10.16%-31.11M-19.73%-8.3M-7.43%-8.13M-1.95%-7.32M-12.18%-7.37M-1.52%-28.24M0.40%-6.93M10.17%-7.56M
Net non-operating interest income expense 304.29%1.23M55.22%357K1,392.77%1.07M74.45%239K2,408.33%301K465.06%303K254.36%230K-1,022.22%-83K179.19%137K105.74%12K
Non-operating interest income 172.40%1.28M5.54%438K177.19%1.68M6.01%353K134.22%438K496.20%471K6,816.67%415K-29.98%605K712.20%333K18,600.00%187K
Non-operating interest expense -65.48%58K-56.22%81K-12.21%604K-41.84%114K-21.71%137K3.70%168K19.35%185K-19.53%688K-8.41%196K-16.67%175K
Other net income (expense)
Income before tax -57.37%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.39%-7.01M-6.27%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M
Income tax 0.00%1K0.00%1K001K0.00%1K00
Net income -57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M
Net income continuous Operations -57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M
Minority interest income
Net income attributable to the parent company -57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M
Basic earnings per share 54.05%-0.1730.95%-0.2915.05%-1.582.50%-0.3920.00%-0.426.00%-0.378.70%-0.4242.59%-1.8642.86%-0.449.49%-0.5
Diluted earnings per share 54.05%-0.1730.95%-0.2915.05%-1.582.50%-0.3920.00%-0.426.00%-0.378.70%-0.4242.59%-1.8642.86%-0.449.49%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data